Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-17 8:12 pm Sale |
2025-06-30 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
1,813,695 2.900% |
-3,591,806 (-66.45%) |
Filing History |
| 2025-07-07 7:20 pm Purchase |
2025-06-01 | 13G | MacroGenics, Inc. MGNX |
Bellevue Group AG | 9,929,963 15.700% |
9,929,963 (New Position) |
Filing History |
| 2025-06-13 2:50 pm Sale |
2025-06-01 | 13G | MacroGenics, Inc. MGNX |
BB BIOTECH AG | 0 0.000% |
-9,929,963 (Position Closed) |
Filing History |
| 2025-05-15 3:31 pm Purchase |
2025-03-31 | 13G | MacroGenics, Inc. MGNX |
ARMISTICE CAPITAL LLC | 6,296,000 9.980% |
20,000 (+0.32%) |
Filing History |
| 2025-04-17 4:00 pm Sale |
2025-03-31 | 13G | MacroGenics, Inc. MGNX |
Integrated Core Strategies (US) LLC | 1,724,250 2.700% |
-1,485,724 (-46.28%) |
Filing History |
| 2025-02-14 6:39 pm Sale |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
RA Capital Management, L.P. | 0 0.000% |
-4,053,077 (Position Closed) |
Filing History |
| 2025-02-14 5:52 pm Purchase |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
ARMISTICE CAPITAL LLC | 6,276,000 9.990% |
18,000 (+0.29%) |
Filing History |
| 2025-02-14 2:39 pm Unchanged |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
BB BIOTECH AG | 9,929,963 15.800% |
0 (Unchanged) |
Filing History |
| 2025-02-11 5:37 pm Purchase |
2024-12-31 | 13G | MacroGenics, Inc. MGNX |
WASATCH ADVISORS LP | 3,488,493 5.600% |
1,246,131 (+55.57%) |
Filing History |
| 2024-11-20 10:44 am Purchase |
2024-11-14 | 13G | MacroGenics, Inc. MGNX |
Frazier Life Sciences Public Fund, L.P. | 3,175,665 5.100% |
3,175,665 (New Position) |
Filing History |
| 2024-11-14 5:13 pm Purchase |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
ARMISTICE CAPITAL LLC | 6,258,000 9.980% |
1,686,000 (+36.88%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,405,501 8.600% |
0 (Unchanged) |
Filing History |
| 2024-10-22 3:24 pm Sale |
2024-09-30 | 13G | MacroGenics, Inc. MGNX |
BlackRock Inc. BLK |
5,405,501 8.600% |
-734,848 (-11.97%) |
Filing History |
| 2024-06-04 4:53 pm Purchase |
2024-06-03 | 13G | MacroGenics, Inc. MGNX |
Integrated Core Strategies (US) LLC | 3,209,974 5.100% |
505,258 (+18.68%) |
Filing History |
| 2024-05-21 4:12 pm Sale |
2024-05-14 | 13G | MacroGenics, Inc. MGNX |
Integrated Core Strategies (US) LLC | 2,704,716 4.300% |
-102,519 (-3.65%) |
Filing History |
| 2024-02-14 5:01 pm Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
RA Capital Management, L.P. | 4,053,077 6.500% |
288,206 (+7.66%) |
Filing History |
| 2024-02-14 2:29 pm Sale |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
ARMISTICE CAPITAL LLC | 4,572,000 7.370% |
-1,520,000 (-24.95%) |
Filing History |
| 2024-02-14 10:04 am Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
T. Rowe Price Investment Management Inc. | 5,639,994 9.100% |
5,639,994 (New Position) |
Filing History |
| 2024-02-13 5:08 pm Sale |
2023-12-29 | 13G | MacroGenics, Inc. MGNX |
The Vanguard Group | 4,309,394 6.950% |
-134,970 (-3.04%) |
Filing History |
| 2024-02-13 06:13 am Purchase |
2023-12-31 | 13G | MacroGenics, Inc. MGNX |
BB BIOTECH AG | 9,929,963 16.000% |
1,000,000 (+11.20%) |
Filing History |